Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
4-[(5-chloroindol-2-yl)sulfonyl]-2-(2-methylpropyl)-1-[[5-(pyridin-4-yl)pyrimidin-2-yl]carbonyl]piperazine
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is an experimental small molecule with the chemical formula C26H27ClN6O3S and a molecular weight of approximately 539.05 g/mol. It is catalogued in DrugBank as DB04673 and has not been approved for any indication in the US or elsewhere. There are no reported clinical trials, patents, or approved uses for this molecule. The structure features a piperazine core substituted with indole, sulfonamide, pyridine, and pyrimidine moieties—characteristics common to kinase inhibitors and other targeted agents; however, there is no publicly available information on its mechanism of action or therapeutic target[1][7]. It remains an experimental research compound.
- Other names
- DB04673DB-04673DB 04673
Beyond the preview
Go deeper on 4-[(5-chloroindol-2-yl)sulfonyl]-2-(2-methylpropyl)-1-[[5-(pyridin-4-yl)pyrimidin-2-yl]carbonyl]piperazine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 4-[(5-chloroindol-2-yl)sulfonyl]-2-(2-methylpropyl)-1-[[5-(pyridin-4-yl)pyrimidin-2-yl]carbonyl]piperazine.